Search Results 1311-1320 of 20121 for Hepatitis C

  1. Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 - Mayo Clinic

    ... hepatitis B, hepatitis C or HIV infection; For melanoma: Uveal melanoma or LDH >1.1 x ULN; Brain metastases considered unstable as: Without confirmed ...

  2. Dr. Julie Heimbach Archives - Mayo Clinic News Network

    more time between organ retrieval and transplant. Antiviral drugs can also be used to help eliminate the hepatitis C risk for people accepting an organ from an ...

  3. Publications - Ameet C. Patel, M.D. - Mayo Clinic

    Xu N, Zhou Y, Patel A, Zhang N, Liu Y. Parkinson's Disease Diagnosis beyond Clinical Features: A Bio-marker using Topological Machine Learning of ...

  4. A Study Of BMS-986340 In Combination With Nivolumab, Gemcitabine And Nab-paclitaxel In The First Line Setting Of Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    hepatitis C (note that subjects with hepatitis C who have been clinically cured, defined as persistent absence of hepatitis C ribonucleic acid (RNA) ...

  5. A Study to Evaluate the Safety, Tolerance and Anti-tumor Activity of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    Active hepatitis A, B, and C as defined below: active hepatitis A (defined as positive IgM), active hepatitis B (defined as either positive hepatitis B ...

  6. Ritonavir (oral route) - Side effects & dosage - Mayo Clinic

    Liver disease (eg, hepatitis B or C) or; Pancreatitis (inflammation of the pancreas)—Use with caution. May make these conditions worse. Hemophilia (a ...

  7. Stacey A. Rizza, M.D. - Doctors and Medical Staff - Mayo Clinic

    Work GroupHepatitis C Curriculum, Infectious Diseases Society of America. 2012. Scientific ReviewerNational Institutes of Health. 2012. Scientific ReviewerRFA ...

  8. Study Of ABBV-383 Assessing Adverse Events And Clinical Activity With Subcutaneous (SC) Injection In Adult Participants With Relapsed Or Refractory Multiple Myeloma

    Subject has evidence of active hepatitis C infection based on screening blood testing;. Subject may not be seropositive for hepatitis C, except in the ...

  9. A Global Study To Assess The Drug Dynamics, Efficacy, And Safety Of GZ/SAR402671 In Parkinson's Disease Patients Carrying A Glucocerebrosidase (GBA) Gene Mutation - Mayo Clinic

    ... hepatitis B immunization are eligible if other criteria are met (ie, negative tests for : HBsAg, hepatitis B core antibody [HBcAb],and hepatitis C [HCVAb].

  10. Maraviroc (oral route) - Side effects & dosage - Mayo Clinic

    Make sure you tell your doctor if you have any other medical problems, especially: Heart disease or; Liver problems (eg, hepatitis B or C), history of or ...